Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents

This publication has 44 references indexed in Scilit:

• Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
  Immunity, 1999
• Suppression of Experimental Autoimmune Encephalomyelitis by Tyrphostin AG-556
  Experimental Neurology, 1998
• PDGF-Receptor Tyrosine Kinase Blocker AG1295 Selectively Attenuates Smooth Muscle Cell Growth In Vitro and Reduces Neointimal Formation After Balloon Angioplasty in Swine
  Circulation, 1998
• The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways
  Proceedings of the National Academy of Sciences, 1996
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
  Nature Medicine, 1996
• Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor
  Journal of Medicinal Chemistry, 1996
• Tyrphostins suppress the growth of psoriatic keratinocytes
  Experimental Dermatology, 1995
• RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
  Proceedings of the National Academy of Sciences, 1995
• A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
  Science, 1994
• The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
  Journal of Cell Biology, 1991